Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,863 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 46,863 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 29, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.24 | $76.88 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,747 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 28, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,685 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 25, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.23 | $76.26 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,623 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 24, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.24 | $76.88 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,561 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 23, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.26 | $78.12 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,499 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 22, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,437 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 21, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,375 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 18, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.28 | $79.36 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,313 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 17, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.30 | $80.60 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,251 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 16, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.25 | $77.50 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,189 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 15, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.30 | $80.60 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,127 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 14, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.37 | $84.94 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,065 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 11, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.39 | $86.18 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,003 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 10, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.32 | $81.84 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,941 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 09, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.31 | $81.22 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,879 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 08, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.30 | $80.60 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,817 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 07, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.29 | $79.98 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,755 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 04, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.28 | $79.36 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,693 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 03, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.28 | $79.36 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,631 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 02, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.29 | $79.98 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,569 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| October 01, 2024 Filed Nov 5, 2024 21:39 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 62 | $1.27 | $78.74 |
DisclosureSEC source: 0001628280-24-045331 · wk-form4_1730842772.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,507 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 62 | $1.36 | $84.32 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,445 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 27, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.24 | $54.56 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,383 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 26, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.24 | $62.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,339 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 25, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 39 | $1.29 | $50.31 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,289 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 24, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $1.22 | $18.30 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,250 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 23, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.25 | $62.50 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,235 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 20, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,185 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 19, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.29 | $64.50 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,135 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 18, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,085 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 17, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,035 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 16, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,985 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 13, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.30 | $65.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,935 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 12, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.35 | $67.50 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,885 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 11, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 48 | $1.35 | $64.80 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,835 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 10, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 31 | $1.30 | $40.30 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,787 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 09, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.33 | $66.50 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,756 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 06, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 10 | $1.30 | $13.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,706 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 05, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 46 | $1.28 | $58.88 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,696 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 04, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 47 | $1.35 | $63.45 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,650 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| September 03, 2024 Filed Oct 3, 2024 20:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.38 | $69.00 |
DisclosureSEC source: 0001628280-24-042120 · wk-form4_1727986080.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,603 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person March 13, 2024. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 27 | $1.35 | $36.45 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,553 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 29, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.41 | $70.50 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,526 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 28, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.40 | $70.00 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,476 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 27, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 29 | $1.40 | $40.60 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,426 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 26, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $1.37 | $68.50 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,397 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 23, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 42 | $1.38 | $57.96 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,347 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 22, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.40 | $61.60 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,305 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 21, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 36 | $1.39 | $50.04 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,261 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 20, 2024 Filed Sep 4, 2024 21:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 45 | $1.35 | $60.75 |
DisclosureSEC source: 0001214659-24-016020 · marketforms-66912.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,225 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.